default author photo

Nabihah Tayob

Harvard University - Dana-Farber Cancer Institute

Boston, MA

United States

  • Harvard University - Dana-Farber Cancer Institute

SCHOLARLY PAPERS

1

DOWNLOADS

15

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Phase 2 Study of Wee1 Inhibitor Adavosertib in Recurrent Uterine Carcinosarcoma

Number of pages: 32 Posted: 03 Jun 2025
Stephanie Cham, Niya Xiong, Nabihah Tayob, Carolyn Krasner, Alexi A. Wright, Elizabeth Katherine Lee, Hannah Sawyer, Cara A. Mathews, Panagiotis A. Konstantinopoulos, Ursula Matulonis and Joyce Liu
affiliation not provided to SSRN, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Brown University - Department of Obstetrics and Gynecology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute and Harvard University - Dana-Farber Cancer Institute
Downloads 15 (1,500,778)

Abstract:

Loading...

uterine carcinosarcoma, Wee1 inhibitor, TP53 mutation, phase 2 trial, next generation sequencing